<- Go Home
Novartis India Limited
Novartis India Limited is involved in the pharmaceutical business in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neuroscience products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is headquartered in Mumbai, India. The company is a subsidiary of Novartis AG.
Market Cap
INR 20.0B
Volume
9.9K
Cash and Equivalents
INR 6.2B
EBITDA
INR 937.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 1.6B
Profit Margin
44.46%
52 Week High
INR 1.1K
52 Week Low
INR 744.95
Dividend
3.09%
Price / Book Value
2.58
Price / Earnings
18.74
Price / Tangible Book Value
2.58
Enterprise Value
INR 13.8B
Enterprise Value / EBITDA
14.50
Operating Income
INR 933.9M
Return on Equity
14.17%
Return on Assets
6.40
Cash and Short Term Investments
INR 6.2B
Debt
INR 40.5M
Equity
INR 7.8B
Revenue
INR 3.5B
Unlevered FCF
INR 136.9M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium